{
  "id": 3654862,
  "title": "McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization",
  "url": "https://urgent.news/2026/08/25/mckesson-buys-precision-medicine-to-expand-clinical-research-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-25T15:31:16.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/healthcare/articles/mckesson-buys-precision-medicine-expand-153116988.html"
  },
  "original_language": "en",
  "account": "On Tuesday, McKesson Corporation announced it had reached an agreement to acquire Precision Medicine Group for approximately $2.25 billion. The acquisition will allow McKesson to expand its offerings in clinical research and commercialization services. Following the completion of the transaction, Precision Medicine Group will be under the management of McKesson's Oncology & Multispecialty segment, which is its second-largest segment with first-quarter sales reaching $14.2 billion. McKesson's financials as of the first quarter included cash and equivalents totaling $5.20 billion. Precision Medicine Group provides advanced solutions for drug development and commercialization, utilizing biotechnology and pharmaceutical companies in their processes. These technologies include biomarker intelligence, lab services, a global clinical research organization, market access consulting, and commercialization support. Despite a mixed moving-average trend, with the 20-day Simple Moving Average ($865.80) above the 50-day Simple Moving Average ($822.98), and a longer-term death cross pattern observed, the stock has seen a 28.70% increase over the past year. Currently priced above its 20-day and 50-day moving averages, the stock is trading at $873.29, up 1.22% as of publication on Tuesday. Analysts generally view McKesson with a moderate outlook, rating the stock as a 'Buy' with an average price target of $986.56.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}